UPDATE 1-U.S. lawmakers ask Gilead about Sovaldi pricing
March 21, 2014 at 11:14 AM EDT
March 21 (Reuters) - U.S. lawmakers have asked Gilead Sciences Inc for a briefing on the price of its new hepatitis C drug Sovaldi, which can cost more than $80,000 per patient.
